DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings You may also like 12:31 Santhera Pharmaceuticals 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 10:23 Cumberland Pharmaceuticals 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 7:11 Epirium Bio 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:46 NS Pharma 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 6 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation «1…2324252627…29»Page 25 of 29